From Medscape Neurology

34th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2018

October 10 - 12, 2018; Berlin, Germany

October 10 - 12, 2018 Berlin, Germany

ECTRIMS 2018 Stem Cell Transplant Effective as First Line in Aggressive MS Stem cell treatment for MS is now becoming safe and highly effective for certain patients with very active disease, latest data suggest.
Medscape Medical News, October 15, 2018
ECTRIMS 2018 Natalizumab or Fingolimod After First-Line Drugs in MS? A new propensity score analysis suggests natalizumab may have the edge over fingolimod for patients who experience relapse on first-line drugs, especially patients with more active disease.
Medscape Medical News, October 11, 2018
ECTRIMS 2018 Treadmill Walking Speeds Up Cognition in MS A new study found that treadmill walking produced a statistically and clinically significant improvement in cognition in patients with multiple sclerosis.
Medscape Medical News, October 11, 2018

ECTRIMS 2018 Higher BMI Linked to Lower Brain Volume in MS
Medscape Medical News, November 7, 2018
ECTRIMS 2018 Nearly 1 in 5 Patients Referred for MS Are Misdiagnosed
Medscape Medical News, October 31, 2018
ECTRIMS 2018 'Interesting' Latest Results With Antiretroviral Antibody in MS
Medscape Medical News, October 30, 2018
ECTRIMS 2018 Switching to Alemtuzumab in MS, Keep Washout to a Minimum
Medscape Medical News, October 24, 2018
ECTRIMS 2018 Evidence Mounts for Promise of MS Serum Biomarker
Medscape Medical News, October 23, 2018
ECTRIMS 2018 McDonald Criteria 2017 Boost MS Diagnoses by 25%
Medscape Medical News, October 23, 2018
ECTRIMS 2018 Fluoxetine, Riluzole or Amiloride No Benefit in Progressive MS
Medscape Medical News, October 23, 2018
ECTRIMS 2018 Safe to Stop MS Disease-Modifying Therapy After Age 60?
Medscape Medical News, October 19, 2018
ECTRIMS 2018 Novel Anti-B-Cell Therapy Looks Promising in MS
Medscape Medical News, October 18, 2018

ECTRIMS 2018 Satralizumab Slashes Relapse Rate in Neuromyelitis Optica
Medscape Medical News, October 17, 2018
ECTRIMS 2018 Vitamin D Boosts, Smoking Clouds Cognition in MS
Medscape Medical News, October 15, 2018
ECTRIMS 2018 Stem Cell Transplant Effective as First Line in Aggressive MS
Medscape Medical News, October 15, 2018
ECTRIMS 2018 iPad 9-Hole Peg Test Correlates With MS Imaging
Medscape Medical News, October 15, 2018
ECTRIMS 2018 'Burning Debate' on McDonald Diagnostic Criteria in MS
Medscape Medical News, October 12, 2018
ECTRIMS 2018 Natalizumab or Fingolimod After First-Line Drugs in MS?
Medscape Medical News, October 11, 2018
ECTRIMS 2018 Treadmill Walking Speeds Up Cognition in MS
Medscape Medical News, October 11, 2018
ECTRIMS 2018 Familial MS May Have a More Aggressive Course
Medscape Medical News, October 10, 2018

New MS Diagnostic Criteria Will Allow Earlier Diagnosis The updated McDonald criteria allow CSF findings and symptomatic MRI lesions to be considered for the diagnosis of multiple sclerosis.
Medscape Medical News, Oct 27, 2017
European MS Treatment Guidelines Released The first real guidelines on the use of disease-modifying therapies cover the treatment of adults with MS or CIS, the monitoring of treatment response, the stopping and switching of treatment strategies, and treatment in special situation, such as pregnancy.
Medscape Medical News, Oct 27, 2017
Benign MS: Does It Exist? New data on estimates of benign MS have provoked strong conflicting opinions on its actual incidence and the recommended treatment approaches.
Medscape Medical News, Nov 20, 2017

Medscape Neurology© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

PERSPECTIVES

Previous Coverage

Related Resource